Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

Reports positive preliminary first quarter revenues of $12.5 Million up 13% versus prior year. Over 70 ePlex customer agreements totaling more than 100 analyzers in place at the end of first quarter. GenMark Diagnostics, a provider of automated, multiplex molecular diagnostic testing systems, announced it has achieved CE Mark under the European In‐Vitro Diagnostic Devices Directive (98/79/EC) for its ePlex Blood Culture Identification Fungal Pathogen (BCID-FP) panel. BCID-FP is the first panel in the GenMark Sepsis Solution, which will also include BCID Gram-Positive and Gram-Negative panels.

Read more ...

Cellnovo, a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, and digital health company TypeZero Technologies, announce the completion of a worldwide commercial license agreement for the integration and the commercialization of TypeZero’s Artificial Pancreas (AP) technology into Cellnovo’s mobile diabetes management systems.

The non-exclusive worldwide agreement allows Cellnovo to commercialize a Cellnovo-TypeZero product in the future. Integration efforts are currently underway with a product launch expected in 2018. No financial terms have been disclosed.

Read more ...

Cooperative Research and Development Agreement (CRADA) to advance and qualify ‘Human Emulation System’ to meet regulatory evaluation criteria for product testing. Emulate announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration’s (FDA) Office of Foods and Veterinary Medicine. Under this multi-year CRADA, Emulate and FDA will collaborate to evaluate and qualify the use of Emulate’s Organs-on-Chips technology as a platform for toxicology testing to meet regulatory evaluation criteria for products – including foods, dietary supplements and cosmetics.

Read more ...

Tronics, a TDK Group company that designs and manufactures innovative nano and microsystems, has announced the opening of a MEMS production facility located in Addison, Texas, near Dallas. The fab expands Tronics’ MEMS development and manufacturing capabilities in North America.

Read more ...

Abbott and Alere announced that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere. Under the amended terms, Abbott will pay $51 per common share to acquire Alere, for a new expected equity value of approximately $5.3 billion, reduced from the originally expected equity value of approximately $5.8 billion.

Read more ...

“Currently worth a few million dollars, the emerging organs-on-a-chips market has the potential to become a multi-billion dollar market”, announces Sébastien Clerc, Medical Technologies Analyst at Yole Développement (Yole). Pioneers started the development of organs-on-chips around 2000 but really accelerated only after 2010 thanks to government initiatives substantial funding and rising awareness. Yole’s MedTech team is announcing today a real market, in its new technology & market analysis titled Organs-on-a-chips.

Read more ...

Upcoming Events


> Lab-on-a-Chip & Microfluidics 2017
(May 10 - May 11, Munich, Germany)

Webcast

No events

Presentation

Medical and Healthcare: What are the opportunities for MEMS and sensors?
Discover the presentation held by Benjamin Roussel at ATW on Microelectronics, Systems and P...
What’s going on in the world of Solid State Medical Imaging?
Discover the presentation held by Jérôme Mouly at MediSens, in London, UK, in December 2016.
Microfluidics for Point-of-Need Testing: Market & Technology Analysis
Discover the presentation held by Sebastien Clerc at LOAC World 2016, the 27th of September ...

Access to all our presentations